NCT00059449View on ClinicalTrials.gov

Role of Epidermal Growth Factor (EGF) in Development of Necrotizing Enterocolitis

CompletedOBSERVATIONAL

Enrollment

372

Participants

Timeline

Start Date

Not specified

Conditions

Necrotizing EnterocolitisPremature Birth

Trial Locations (3)

45220

Good Samaritan Hospital, Cincinnati

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

University Hospital, Cincinnati

All Listed Sponsors

lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH